Etanercept AL amyloidosis.

Suppr

超能文献

作者信息

Drewe E, Powell R J

出版信息

Lancet. 2001 Sep 1;358(9283):761. doi: 10.1016/S0140-6736(01)05913-X.

DOI:10.1016/S0140-6736(01)05913-X

PMID:11556345

Abstract

摘要

相似文献

Etanercept AL amyloidosis.

Lancet. 2001 Sep 1;358(9283):761. doi: 10.1016/S0140-6736(01)05913-X.

Treatment of necrobiosis lipoidica with the tumor necrosis factor antagonist etanercept.

J Am Acad Dermatol. 2006 Mar;54(3 Suppl 2):S120-1. doi: 10.1016/j.jaad.2005.11.1042.

[Etanercept: enbrel].

Ann Dermatol Venereol. 2007 Dec;134(12):972-7. doi: 10.1016/s0151-9638(07)78260-1.

Multicentric reticulohistiocytosis treated successfully with an anti-tumor necrosis factor agent: comment on the article by Gorman et al.

Arthritis Rheum. 2003 Mar;48(3):864-6. doi: 10.1002/art.10781.

Palmoplantar pustulosis with arthro-osteitis: successful treatment with etanercept and acitretin.

J Eur Acad Dermatol Venereol. 2009 Jul;23(7):854-5. doi: 10.1111/j.1468-3083.2008.03053.x.

Treatment of renal amyloidosis with etanercept in tumour necrosis factor receptor-associated periodic syndrome.

Rheumatology (Oxford). 2004 Nov;43(11):1405-8. doi: 10.1093/rheumatology/keh357. Epub 2004 Aug 17.

Etanercept treatment patterns in managed-care patients with psoriasis or psoriatic arthritis.

J Med Econ. 2010;13(2):228-35. doi: 10.3111/13696998.2010.487469.

A novel therapeutic approach to erythema annulare centrifugum.

J Am Acad Dermatol. 2006 Mar;54(3 Suppl 2):S134-5. doi: 10.1016/j.jaad.2005.11.1044.

Etanercept treatment in corticosteroid-dependent myasthenia gravis.

Neurology. 2004 Dec 28;63(12):2390-2. doi: 10.1212/01.wnl.0000147242.92691.71.

The role of the QuantiFERON-TB Gold test as screening prior to administration of tumor necrosis factor inhibitors.

Arch Dermatol. 2007 Jun;143(6):809-10. doi: 10.1001/archderm.143.6.809.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Etanercept AL amyloidosis.

Lancet. 2001 Sep 1;358(9283):761. doi: 10.1016/S0140-6736(01)05913-X.

Treatment of necrobiosis lipoidica with the tumor necrosis factor antagonist etanercept.

J Am Acad Dermatol. 2006 Mar;54(3 Suppl 2):S120-1. doi: 10.1016/j.jaad.2005.11.1042.

[Etanercept: enbrel].

Ann Dermatol Venereol. 2007 Dec;134(12):972-7. doi: 10.1016/s0151-9638(07)78260-1.

Multicentric reticulohistiocytosis treated successfully with an anti-tumor necrosis factor agent: comment on the article by Gorman et al.

Arthritis Rheum. 2003 Mar;48(3):864-6. doi: 10.1002/art.10781.

Palmoplantar pustulosis with arthro-osteitis: successful treatment with etanercept and acitretin.

J Eur Acad Dermatol Venereol. 2009 Jul;23(7):854-5. doi: 10.1111/j.1468-3083.2008.03053.x.

Treatment of renal amyloidosis with etanercept in tumour necrosis factor receptor-associated periodic syndrome.

Rheumatology (Oxford). 2004 Nov;43(11):1405-8. doi: 10.1093/rheumatology/keh357. Epub 2004 Aug 17.

Etanercept treatment patterns in managed-care patients with psoriasis or psoriatic arthritis.

J Med Econ. 2010;13(2):228-35. doi: 10.3111/13696998.2010.487469.

A novel therapeutic approach to erythema annulare centrifugum.

J Am Acad Dermatol. 2006 Mar;54(3 Suppl 2):S134-5. doi: 10.1016/j.jaad.2005.11.1044.

Etanercept treatment in corticosteroid-dependent myasthenia gravis.

Neurology. 2004 Dec 28;63(12):2390-2. doi: 10.1212/01.wnl.0000147242.92691.71.

The role of the QuantiFERON-TB Gold test as screening prior to administration of tumor necrosis factor inhibitors.

Arch Dermatol. 2007 Jun;143(6):809-10. doi: 10.1001/archderm.143.6.809.